China’s SFDA Creates New Regulations And System To Monitor Medical Device Adverse Events
This article was originally published in PharmAsia News
SHANGHAI - China's State FDA has issued new regulations on the reporting and monitoring of adverse events tied to medical devices
You may also be interested in...
Insider Analysis From Asia Pacific Bio Intelligence LLC On China State FDA’s Medical Device Regulations
For China’s State FDA, 2011 was a banner year, with regulations released on good manufacturing practices for both drugs and devices. Multinational companies should take notice and be sure their operations are in compliance.
BEIJING - An array of regulatory and legal changes covering pharmaceuticals and medical devices in China is likely to be launched or broadened this year, including new GMP guidelines, as the country aims to upgrade supervision of the entire health care sector, according to a leading Chinese lawyer in the area of life sciences-related issues and legislation
SHANGHAI - China has reorganized the Ministry of Health and put the State FDA under its jurisdiction. The State Council's institutional restructuring scheme was officially approved March 15 at the first session of the 11 National People's Congress held in Beijing